✦ LIBER ✦

Myelodysplastic Syndromes and Secondary Acute Myelogeneous Leukemia: Directions for the New Millennium

✍ Scribed by Yataro Yoshida

Publisher: Carden Jennings Publishing
Year: 2002
Tongue: English
Weight: 35 KB
Volume: 75
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf02982055

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose cytosine arabinoside in the mye

Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia

✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Intensive antileukemic treatment of pati

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia

✍ T. de Witte; P. Muus; B. de Pauw; C. Haanen 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Thiotepa, busulfan, and cyclophosphamide

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

✍ Samer Bibawi; Dima Abi-Said; Luis Fayad; Paolo Anderlini; Naoto T. Ueno; Rakesh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Therapy-related acute myelogenous leukem

✍ Dushyant Verma; Susan O'Brien; Deborah Thomas; Stefan Faderl; Charles Koller; Sh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## BACKGROUND: Secondary malignancies including myeloid neoplasms occur infrequently in acute lymphoblastic leukemia (ALL) and to the authors' knowledge have not been as well documented in adults as in children. ## METHODS: A total of 641 patients with de novo ALL who were treated wi

Cost and effectiveness of reduced-intens

Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome

✍ Osamu Imataki; Takeshi Kamioka; Takashi Fukuda; Ryuji Tanosaki; Yoichi Takaue 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 163 KB

Prediction of therapy-related acute myel

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma

✍ Legare, Robert D.; Gribben, John G.; Maragh, Marlon; Hermanowski-Vosatka, Anne; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th